Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazolonylquinolines and the use thereof as ATM kinase inhibitors

Imidazolonylquinolines and the use thereof as ATM kinase inhibitors

US Patent 11608338 · Granted Mar 21, 2023

Estimated economic value: $416,347,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazolonylquinoline compounds and therapeutic uses thereof2025
Thiazolopyridine derivatives as adenosine receptor antagonists2025
Benzimidazole derivatives as adenosine receptor antagonists2022
Quinoxaline derivatives as adenosine receptor antagonists2021
Thiazolopyridine derivatives as adenosine receptor antagonists2021
Crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)p2021
Arylquinazolines2021
Solid form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]2021
Imidazolonylquinolines and the use thereof as ATM kinase inhibitors2021
Imidazolonylquinolines and the use thereof as ATM kinase inhibitors2021
Imidazolonylquinolines and the use thereof as ATM kinase inhibitors2020
Imidazolonylquinolines and the use thereof as ATM kinase inhibitors2020